Intraoral Aging of 3D Printed Orthodontic Aligners
NCT07926035, Not applicable, Completed, Alexandria University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Intraoral Aging of 3D Printed Orthodontic Aligners | ClinicalTrials.gov |
| NCT number | NCT07926035 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 12 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Alexandria University | ClinicalTrials.gov |
| Conditions | Orthodontic Aligners | ClinicalTrials.gov |
| Interventions | TC-85 directly 3D-printed aligner, TA-28 directly 3D-printed aligner | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in indentation hardness (HIT), measured by instrumented nanoindentation | Baseline (unused aligner) and after 2 weeks of intraoral use | Indentation hardness (HIT, GPa) of directly 3D-printed TC-85 and TA-28 aligners, measured by instrumented nanoindentation using a Nano Indenter XP (MTS Systems Corporation, USA) with a Berkovich diamond indenter. Tests were displacement-controlled to a maximum depth of 2000 nm at a constant strain rate of 0.05 s-¹, with 25 indentations per specimen spaced 30 μm apart. Testing followed ISO 14577-1:2015 and data were analyzed by the Oliver and Pharr method. Retrieved aligners are compared with unused aligners printed from the same digital design. | ClinicalTrials.gov |
| Secondary | Change in indentation elastic modulus (EIT), measured by instrumented nanoindentation | Baseline (unused aligner) and after 2 weeks of intraoral use | Indentation elastic modulus (EIT, GPa) of directly 3D-printed TC-85 and TA-28 aligners, measured by instrumented nanoindentation using a Nano Indenter XP (MTS Systems Corporation, USA) with a Berkovich diamond indenter. Tests were displacement-controlled to a maximum depth of 2000 nm at a constant strain rate of 0.05 s-¹, with 25 indentations per specimen spaced 30 μm apart. A Poisson's ratio of 0.4 was assumed. Testing followed ISO 14577-1:2015 and data were analyzed by the Oliver and Pharr method. Retrieved aligners are compared with unused aligners printed from the same digital design. | ClinicalTrials.gov |
| Secondary | Change in color (ΔE₀₀, CIEDE2000), measured by UV-visible spectrophotometry | Baseline (unused aligner) and after 2 weeks of intraoral use | Color of directly 3D-printed TC-85 and TA-28 aligners measured with a UV-visible spectrophotometer (V-770, JASCO Corporation, Tokyo, Japan). Each aligner was sectioned along the right central incisor-canine region, and the labial surface was positioned in a standardized manner facing the incident-light window. CIE Lab\* coordinates were recorded according to ISO 11664-4:2019, and the color change between unused and retrieved aligners was calculated as ΔE₀₀ using the CIEDE2000 equation (parametric factors set to 1). Values are interpreted against 0.8 (50:50% perceptibility) and 1.8 (50:50% acceptability). | ClinicalTrials.gov |
| Secondary | Change in light transmittance and absorbance (400-700 nm), measured by UV-visible spectrophotometry | Baseline (unused aligner) and after 2 weeks of intraoral use | Light transmittance and absorbance of TC-85 and TA-28 aligners recorded across the visible range (400-700 nm) with a UV-visible spectrophotometer (V-770, JASCO Corporation, Tokyo, Japan) using Spectra Manager II software, after calibration according to the manufacturer's instructions. Values at 400 and 700 nm were extracted from each spectrum and compared between materials and between unused and retrieved aligners. | ClinicalTrials.gov |
| Secondary | Change in aligner thickness (μm), measured by confocal laser scanning microscopy | Baseline (unused aligner) and after 2 weeks of intraoral use | Thickness of TC-85 and TA-28 aligners measured by confocal laser scanning microscopy (Leica DMi8, Leica Microsystems, Wetzlar, Germany) with a 10× objective and 1.5× digital zoom under standardized imaging conditions. Standardized 4 × 4 mm specimens were taken from the labial surface of the left central incisor region. Z-stack images were reconstructed in 3D using Leica LAS AF software (version 1.1.0.12420), and thickness was calculated as the perpendicular distance between the upper and lower specimen surfaces. Each specimen was measured twice and the mean was used. | ClinicalTrials.gov |
| Secondary | Change in surface roughness (Sa, Sq, Sp, Sv), measured by confocal laser scanning microscopy | Baseline (unused aligner) and after 2 weeks of intraoral use | Surface roughness of the inner surface of directly 3D-printed TC-85 and TA-28 aligners, assessed on the same 4 × 4 mm specimens used for thickness measurement, imaged by confocal laser scanning microscopy (Leica DMi8, Leica Microsystems, Wetzlar, Germany). Height maps generated from the z-stacks with Leica LAS AF software were analyzed in ImageJ (National Institutes of Health, USA) with the SurfCharJ-1q plugin to calculate Sa (arithmetical mean height), Sq (root mean square height), Sp (maximum peak height) and Sv (maximum valley depth), in µm. Analysis was repeated twice per specimen and the mean was used. Identical acquisition and analysis settings were applied to all specimens. | ClinicalTrials.gov |
| Secondary | Change in degree of conversion (DC), measured by ATR-FTIR spectroscopy | Baseline (unused aligner) and after 2 weeks of intraoral use | Degree of conversion (%) of TC-85 and TA-28 aligners, calculated from attenuated total reflectance Fourier-transform infrared (ATR-FTIR) spectra as the reduction of the aliphatic C=C band near 1638 cm-¹ relative to, referenced to the corresponding unset resin. Retrieved aligners are compared with unused aligners. | ClinicalTrials.gov |
| Secondary | Change in chemical structure, assessed by ATR-FTIR spectral analysis | Baseline (unused aligner) and after 2 weeks of intraoral use | Qualitative comparison of ATR-FTIR spectra of unused and retrieved TC-85 and TA-28 aligners, focusing on the O-H/N-H stretching bands (3400-3200 cm-¹), aliphatic C-H bands (about 2920 and 2850 cm-¹), the carbonyl (C=O) band (about 1700 cm-¹) and the C-O/C-O-C region (1200-1000 cm-¹). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)